申请人:Gilead Sciences, Inc.
公开号:US20160024054A1
公开(公告)日:2016-01-28
The present disclosure provides phosphatidylinositol
3
-kinase (PBK) inhibitors of formula (J),
or pharmaceutically acceptable salts thereof, in which A, n, m, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
and R
7
are as defined herein. These compounds are useful for treatment of conditions mediated by one or more PI3K isoforms. The present disclosure further provides pharmaceutical compositions that include a compound of formula (J), or pharmaceutically acceptable salts thereof, and methods of using these compounds and compositions to treat conditions mediated by one or more PI3K isoforms.
本公开提供公式(J)的磷脂酰肌醇3-激酶(PBK)抑制剂,或其药学上可接受的盐,其中A、n、m、R1、R2、R3、R4、R5、R6和R7如本文所定义。这些化合物可用于治疗由一个或多个PI3K亚型介导的疾病。本公开还提供包括公式(J)的化合物或其药学上可接受的盐的制药组合物,以及使用这些化合物和组合物治疗由一个或多个PI3K亚型介导的疾病的方法。